BACKGROUND: Bidimensional tumor measurements are used routinely as surrogates for tumor volume. The purpose this study was to determine whether there is any added benefit in bidimensional or tridimensional measurements over a unidimensional measurement. METHODS: Sixty-nine colorectal hepatic metastases on 19 computed tomography scans (1-8 lesions per scan) from 9 patients were analyzed. Five patients contributed 2-4 scans each (mean, 3 scans). The standard volume of these lesions was determined by the "summation of areas" technique. The maximum axial dimension, the product of the greatest axial dimensions, and several volume estimates (based on the volumes of a sphere, an ellipsoid, and a cube) each were correlated with the standard volume. RESULTS: The maximum axial dimension and the product of the greatest axial dimensions correlated equally with tumor volume (correlation coefficient = 0.93). Surrogate measures based on the equations for a sphere and an ellipsoid underestimated tumor volume, whereas the equation for a cube overestimated volume. CONCLUSIONS: When reporting tumor size, there is no significant added benefit in reporting bidimensional or tridimensional measurements over the maximum axial dimension. Copyright 2001 American Cancer Society.
BACKGROUND: Bidimensional tumor measurements are used routinely as surrogates for tumor volume. The purpose this study was to determine whether there is any added benefit in bidimensional or tridimensional measurements over a unidimensional measurement. METHODS: Sixty-nine colorectal hepatic metastases on 19 computed tomography scans (1-8 lesions per scan) from 9 patients were analyzed. Five patients contributed 2-4 scans each (mean, 3 scans). The standard volume of these lesions was determined by the "summation of areas" technique. The maximum axial dimension, the product of the greatest axial dimensions, and several volume estimates (based on the volumes of a sphere, an ellipsoid, and a cube) each were correlated with the standard volume. RESULTS: The maximum axial dimension and the product of the greatest axial dimensions correlated equally with tumor volume (correlation coefficient = 0.93). Surrogate measures based on the equations for a sphere and an ellipsoid underestimated tumor volume, whereas the equation for a cube overestimated volume. CONCLUSIONS: When reporting tumor size, there is no significant added benefit in reporting bidimensional or tridimensional measurements over the maximum axial dimension. Copyright 2001 American Cancer Society.
Authors: Iva Petkovska; Matthew S Brown; Jonathan G Goldin; Hyun J Kim; Michael F McNitt-Gray; Fereidoun G Abtin; Raffi J Ghurabi; Denise R Aberle Journal: Acad Radiol Date: 2007-04 Impact factor: 3.173
Authors: H Christian Rischke; Teresa Beck; Werner Vach; Gesche Wieser; Anca L Grosu; Wolfgang Schultze-Seemann; Philipp T Meyer; Cordula A Jilg Journal: Eur J Nucl Med Mol Imaging Date: 2014-06-21 Impact factor: 9.236
Authors: Eugene Duke; Jie Deng; Saad M Ibrahim; Robert J Lewandowski; Robert K Ryu; Kent T Sato; Frank H Miller; Laura Kulik; Mary F Mulcahy; Andrew C Larson; Riad Salem; Reed A Omary Journal: J Vasc Interv Radiol Date: 2010-02-20 Impact factor: 3.464
Authors: James O Park; Li-Xuan Qin; Francesco P Prete; Cristina Antonescu; Murray F Brennan; Samuel Singer Journal: Ann Surg Date: 2009-12 Impact factor: 12.969
Authors: Elizabeth Lim; Matthew G Wiggans; Golnaz Shahtahmassebi; Somaiah Aroori; Matthew J Bowles; Christopher D Briggs; David A Stell Journal: HPB (Oxford) Date: 2016-05-20 Impact factor: 3.647